Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Disease area: Respiratory infections

Abstract

Exhaled Nitric oxide (eNO) appears to have a role in the inflammatory process. The pilot data show that there is increased NO production in pneumonia patient, being compared to lung infiltrate of congestion origin.
Objective. To measure and monitor eNO in the exhaled breath air in pneumonia patients beyond antibacterial treatment.
Materials and methods. Patients with lung infiltrate of inflammatory origin (pneumonia) are involved into the study. Exaled NO is being processed on the 1-st and on the 10-th and 14-th days from the beginning of the antibiotic treatment. The eNO level was measured by analyzer (Aerocrine).
Results. Pilot results concerns 25 clinically confirmed cases of pneumonia. Average baseline eNO was 19.86 ppb (p<0.05). All 7 patients with infectious pneumonia was assigned prolonged antibiotic therapy.
After the appropriate antibiotic therapy (7 days) measurement of nitric oxide has been repeated - revealed declines in nitric oxide in 5 patients (from 45 ppb before treatment to 6 ppb after treatment). Clinical improvement was accompanied by a later positive radiological and clinical dynamics (resolution of infiltrates on X-ray, the normalization of the blood test).
In 2 patients with infectious pneumonia high levels of nitric oxide maintained (average 30 ppb). These patients course of antibiotic therapy was extended to 14 days. Decrease rate of nitric oxide in these two patients (average 30 ppb before treatment to 6 ppb after treatment, p<0.05).
Conclusion. Exhaled Nitric oxide might be helpful to decide about duration of antibiotic therapy. Measurement and monitoring of eNO could be considered as a noninvasive marker, and may be a useful alternative for the assessment of pneumonia.

Rating:

Share or cite this content

Citations should be made in the following way:
N. Voskresenska, J. Voicehovska, G. Orlikov (Riga, Latvia). Exhaled NO levels – A new tool in decision-making about antibiotic treatment. Eur Respir J 2013; 42: Suppl. 57, 4160

Member's Comments

No comment yet.

Related content which might interest you: Exhaled nitric oxide and the therapeutic regimens in childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Comparison of exhaled nitric oxide values measured by two offline methods or NO breath Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Exhaled nitric oxide reference values in healthy Tunisian adults Source: Annual Congress 2013 –Various issues in clinical respiratory physiology Year: 2013 Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Assessment of exhaled breath condensate contamination during measurement of nitric oxide metabolites Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Exhaled nitric oxide measurement in the diagnosis and management of pulmonary tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO) Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs Year: 2021 The effect of chlorine exposure on Exhaled Nitric Oxide in asthmatic children attending indoor swimming pool Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Exhaled nitric oxide in the assessment of asthma control Source: Eur Respir J 2007; 30: Suppl. 51, 18s Year: 2007 Inter-instrument variability in exhaled nitric oxide measurement and implications on test interpretation Source: International Congress 2014 – Airway biomarkers Year: 2014 Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Exhaled nitric oxide in asthma: Relationship with breath gymnastic and FeNO levels Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 Alveolar nitric oxide and its role in asthma control assessment Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Exhaled nitric oxide as a biomarker in different COPD phenotypes Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS) Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled NO (FENO50) in COPD - Results from the TIE-study Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016